Soy Isoflavone Supplementation Research Articles

#1526 Effects of dietary intervention on diabetic nephropathy: an umbrella review of systematic review and meta-analysis of randomized controlled trials

Abstract Background and Aims To evaluate the quality of evidence, potential biases, and validity of all available studies on dietary intervention and diabetic nephropathy (DN). Method We conducted an umbrella review of existing meta-analyses of randomized controlled trials (RCTs) that focused on the effects of dietary intervention on DN. Literature searching was performed via PubMed, Embase, Web of Science, Cochrane Database of Systematic Reviews, and hand searching of the reference lists. Systematic reviews and meta-analyses of RCTs that evaluated the effects of any dietary intervention on clinical outcomes of DN were included. Two reviewers evaluated the methodological quality of the included articles through AMSTAR score. In addition, according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE), evidence of each outcome was evaluated and graded as “high”, “moderate”, “low” or “very low” quality to draw conclusions. Additionally, we classified evidence of outcomes into 4 categories (class I to IV and non-significant (NS)). Results We identified 36 meta-analyses of RCTs and 55 clinical outcomes of DN from 395 unique articles (Fig. 1). Moderate quality evidence suggested that probiotics supplementation could significantly improve blood urea nitrogen (BUN), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in DN patients. Low quality evidence indicated that probiotics supplementation significantly improved serum creatinine, urinary albumin creatinine ratio (UACR), fasting blood glucose (FBG), HbA1c and high-density lipoprotein cholesterol (HDL-C) in DN patients. In addition, low quality evidence suggested that a salt restriction diet could significantly improve creatinine clearance rate (CrCl) in patients with DN. Low quality evidence suggested that vitamin D supplementation could significantly improve UACR in patients with DN. Besides, low quality evidence indicated that soy isoflavone supplementation could significantly improve BUN, FBG, TC, triglycerides (TG) and LDL-C in patients with DN. Furthermore, low quality evidence suggested that coenzyme Q10 supplementation could significantly improve HbA1c, TC and HDL-C in patients with DN, and dietary polyphenols also significantly improved HbA1c in patients with DN. Finally, low quality evidence suggested supplementation of antioxidant vitamins could significantly improve serum creatinine, systolic blood pressure, and HbA1c in patients with DN. The remaining outcomes were rated as very low quality due to significant risk of bias, significant heterogeneity, imprecision, and publication bias. Given the small sample size, all significantly associated outcomes were evaluated as class IV evidence (Fig. 2). Conclusion Moderate to low evidence suggests that supplementation with probiotics, vitamin D, soy isoflavones, coenzyme Q10, dietary polyphenols, antioxidant vitamins, and salt-restricted diets may significantly improve clinical outcomes in patients with DN.

The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial

BackgroundNon-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern with a huge burden on health and economic systems. The aim of this study is to evaluate the effect of soy isoflavones supplementation on metabolic status in patients with NAFLD.MethodsIn this randomized clinical trial, 50 patients with NAFLD were randomly allocated to either soy isoflavone or placebo groups for 12 weeks. The soy isoflavone group took 100 mg/d soy isoflavone and the placebo group took the similar tablets containing starch. Anthropometric indices, blood lipids, glycemic parameters and blood pressure were measured at the beginning and at the end of the study.ResultsAt the end of week 12 the level of serum triglyceride (TG), low density lipoprotein (LDL) and total cholesterol (TC) was significantly decreased only in soy isoflavone group compared to baseline (P < 0.05). Although waist circumference (WC) decreased significantly in both groups after 12 weeks of intervention (P < 0.05), hip circumference (HC) decreased significantly only in soy isoflavone group (P = 0.001). No significant changes observed regarding high density lipoprotein (HDL) and blood pressure in both groups. At the end of the study, serum glucose level was significantly decreased in the placebo group compared to baseline (P = 0.047). No significant changes demonstrated in the soy isoflavone group in regard to glycemic parameters (P > 0.05).ConclusionsThis study revealed that soy isoflavones could significantly reduce TG, LDL TC, WC and HC in NAFLD patients.Trial registrationThe Ethics committee of Ahvaz Jundishapur University of Medical Sciences approved the protocol of the present clinical research (IR.AJUMS.REC.1401.155). The study was in accordance with the Declaration of Helsinki. This study’s registered number and date are IRCT20220801055597N1 and 20.09.2022, respectively at https://fa.irct.ir.

Effects of dietary intervention on diabetic nephropathy: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.

To evaluate the quality of evidence, potential biases, and validity of all available studies on dietary intervention and diabetic nephropathy (DN). We conducted an umbrella review of existing meta-analyses of randomized controlled trials (RCTs) that focused on the effects of dietary intervention on DN incidence. The literature was searched via PubMed, Embase, Web of Science, and the Cochrane Database of Systematic Reviews. According to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE), evidence of each outcome was evaluated and graded as "high", "moderate", "low" or "very low" quality to draw conclusions. Additionally, we classified evidence of outcomes into 4 categories. We identified 36 meta-analyses of RCTs and 55 clinical outcomes of DN from 395 unique articles. Moderate-quality evidence suggested that probiotic supplementation could significantly improve blood urea nitrogen (BUN), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels in DN patients. Low-quality evidence indicated that probiotic supplementation significantly improved the serum creatinine concentration, urinary albumin-creatinine ratio (UACR), fasting blood glucose (FBG), HbA1c and high-density lipoprotein cholesterol (HDL-C) in DN patients. In addition, low-quality evidence suggested that a salt restriction diet could significantly improve the creatinine clearance rate (CrCl) in patients with DN. Low-quality evidence suggested that vitamin D supplementation could significantly improve the UACR in patients with DN. In addition, low-quality evidence has indicated that soy isoflavone supplementation could significantly improve BUN, FBG, total cholesterol (TC), triglyceride (TG) and LDL-C levels in patients with DN. Furthermore, low-quality evidence suggested that coenzyme Q10 supplementation could significantly improve HbA1c, TC and HDL-C in patients with DN, and dietary polyphenols also significantly improved HbA1c in patients with DN. Finally, low-quality evidence suggested that supplementation with antioxidant vitamins could significantly improve the serum creatinine concentration, systolic blood pressure, and HbA1c level in patients with DN. Given the small sample size, all significantly associated outcomes were evaluated as class IV evidence. Moderate to low amounts of evidence suggest that supplementation with probiotics, vitamin D, soy isoflavones, coenzyme Q10, dietary polyphenols, antioxidant vitamins, or salt-restricted diets may significantly improve clinical outcomes in patients with DN. https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024512670.

Effects of soy isoflavones on growth performance, antioxidant capacity, non-specific immunity and lipid metabolism of juvenile Chinese mitten crab, Eriocheir sinensis

Soy isoflavones are phytoestrogens that provide protection against some hormonal disorders and regulate several physiological functions in animals. This study investigates the effects of soy isoflavones on body composition, antioxidant activity, non-specific immunity, and lipid metabolism in juvenile Chinese mitten crabs, Eriocheir sinensis. A total of 960 juvenile crabs (1.09 ± 0.01 g) were randomly assigned to 24 tanks (300L), with 40 crabs in each tank in four replicates. The crabs were fed diets (43.5% protein and 7% lipid) with six levels of soy isoflavones (0, 8.8, 15.8, 33.8, 66.8, and 137.0 mg/kg) at 4% BW/day for 56 days. The final biomass and biomass gain of crabs supplemented with 15.8 and 33.8 mg/kg soy isoflavones were significantly higher than those in the control group. The total lipid content in the whole-body and hepatopancreas of the crabs fed 15.8 and 33.8 mg/kg soy isoflavones was significantly lower than in the control group. Compared with the control group, soy isoflavones significantly enhanced the activities of superoxide dismutase, glutathione peroxidase and total antioxidant capacity in the hepatopancreas by 40%, 57% and 79%, respectively, and significantly decreased malondialdehyde content by 24%. The high dietary soy isoflavones levels increased total protein and hemocyanin contents in hemolymph, and alkaline phosphatase activity was also significantly enhanced. The triglyceride contents in the hepatopancreas and hemolymph were significantly lower in the soy isoflavones-supplemented group. Dietary soy isoflavones may reduce lipid accumulation in the hepatopancreas by repressing genes related to lipid synthesis and promoting the expression of lipid oxidation and transport genes. The broken-line model analysis of biomass gain against dietary soy isoflavones levels shows that the optimal supplemental level of soy isoflavones for juvenile crabs is approximately 26.66 mg/kg. Thus, this study suggests that dietary soy isoflavones supplementation can improve growth performance and health and reduce lipid accumulation in the hepatopancreas of juvenile crabs.

Effect of soy isoflavones on bone health among female university students: a pilot study

Low bone mineral density (BMD) has become more common in young women. In postmenopausal women, soy isoflavones have been demonstrated to have a powerful influence on bone health when taken as a food supplement. It is unclear how soy isoflavones affect premenopausal women, though. This study looked at how soy isoflavones affected female university students’ BMD. Thirty female students, aged 18 to 25, were introduced to a Quasi-experimental design, where only 28 could complete the study. Participants received soy isoflavone at 60 mg/day for 28 days. BMD was assessed using dual-energy x-ray absorptiometry (DEXA) before and after supplementation. In addition, twenty-four hours food recall and food frequency questioners (FFQ) were used to evaluate the dietary intake of participants. The prevalence of osteoporosis among participants was 18% osteoporosis, 61% osteopenia and 21% normal. After 4 weeks of intervention, a slight improvement in the BMD was recorded. This improvement was noticed in 33, 59, and 40% of normal,osteopenia, and osteoporosis participants, respectively. Soy isoflavone supplementation can be useful in decreasing the risk of osteopenia among premenopausal women. These promising results ensure the viability of conducting full-scale clinical trials to thoroughly look at the relationship between soy isoflavones and bone health among pre-menopausal women. Keywords: Osteoporosis; Bone mineral density; Soy isoflavone; Saudi Arabia

Abstract P2-06-02: A randomized controlled trial of soy isoflavone intake on mammographic density among Malaysian women

Abstract Introduction: Soy intake is associated with lower breast cancer risk in observational studies of Asian women, but clinical trials of soy isoflavone (ISF) supplements report no effect on biomarkers of breast cancer risk among Caucasian women. To date, there are no such trials among Asian women living in Asia. We conducted a three-armed, randomized controlled trial (RCT) to assess the effects of one-year intervention of soy isoflavone supplements (100mg/day) or soy isoflavones through diet (50mg/day) on mammographic density (MD) change among peri- and postmenopausal Malaysian women. Methodology: Healthy women between 45-65 years old were enrolled between November 2018 and December 2019 at a private tertiary hospital in Malaysia. Women were randomly assigned into the 100mg/day ISF Supplement arm, 50mg/day ISF Diet arm, or Control arm. Dense area was assessed from digital mammograms conducted at enrolment and after 12 months. We compared absolute and relative change in dense area over the study period by study arm using Kruskal Wallis tests. Results: Of the 118 women who received the intervention, 91 women completed the study whilst 27 women (23%) were lost to follow up. After 12 months of intervention, women in the ISF Supplement arm observed a marginally larger decline in dense area (-1.3cm2), compared to women in the ISF Diet arm (-0.5cm2) and Control arm (-0.8cm2), but this difference was not statistically significant (p=0.479). Notably, these effects appear to be stronger and limited to women who enrolled within 5 years of menopause, where up to 6cm2 decline in MD was observed in the ISF Supplement arm, compared to &amp;lt; 1.0cm in the Control arm (p=0.131). Conclusion: This RCT demonstrates a possible causal association between soy ISF intake and lower breast cancer risk among Asian women, specifically around the time of menopause, but these findings will require confirmation in a larger trial. Citation Format: Nadia Rajaram, Beverley Yap, Mikael Eriksson, Shivaani Mariapun, Lee Mei Tan, Hamizah Saat, Evelyn Ho, Nur Aishah Mohd Taib, Geok Lin Khor, Cheng Har Yip, Weang Kee Ho, Per Hall, Soo Hwang Teo. A randomized controlled trial of soy isoflavone intake on mammographic density among Malaysian women [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P2-06-02.

Dietary Soy Isoflavones Prevent Metabolic Disturbs Associated with a Deleterious Combination of Obesity and Menopause.

This study aimed to evaluate the effects of soy isoflavone supplementation (25 mg/kg) on insulin resistance and inflammation in adipose tissue in an experimental model of menopause-obesity. Twenty-four female Wistar rats were ovariectomized (O) and distributed among the groups: OSD-ovariectomized rats submitted to normocaloric standard diet (n = 6); OHF-ovariectomized rats submitted to high-fat diet (n = 9); and OHFI-ovariectomized rats submitted to high-fat diet with isoflavones (n = 9). Weight gain, body adiposity, food and caloric intake, blood pressure, and glucose tolerance were assessed. After 24 weeks, the rats were euthanized; the thoracic blood collected for serum insulin determination and the homeostatic model assessment-insulin resistance) (HOMA-IR) and homeostatic model assessment-β cell (HOMA-β) indices were calculated. Abdominal adipose tissues were removed, weighed, and fixed for immunohistochemical and morphometric studies. Isoflavones decreased weight gain and blood pressure without changing the food and caloric intake (P < .05). Isoflavones did not affect the weight of the abdominal adipose tissue depots (P < .05). Although they did not alter glucose tolerance, the isoflavones reduced HOMA-IR and HOMA-β, serum insulin levels, in addition to reducing adipocytes' size (P < .05). The number of macrophages, lymphocytes, and crown-like structures in adipose tissue was lower in the group treated with isoflavones (P < .05). In conclusion, our data show that dietary soy isoflavones' supplementation prevents many of well-known deleterious combination of obesity and menopause on metabolism, such as body overweight, adipocyte hypertrophy, and hypertension, as well as insulin resistance and adipose tissue inflammation.

The Combined Effect of High-intensity Interval Training and Soy Isoflavone Diet on MicroRNA-133 Gene in Ovariectomized Rats

Background: The combination of exercise and soy extract supplementation decreases cardiac related disease risk in postmenopausal women. Objectives: We assessed the combined impacts of soy isoflavone (IF) supplementation and exercise on the expression of microRNA-133 gene in ovariectomized rats’ hearts. Methods: This study was conducted on 50 female Wistar rats, which were assigned to five groups, including sham-operated (SHAM), ovariectomized (OVX), ovariectomized with soy IF supplementation (OVX + IF), OVX with exercise (OVX + HIIT), and OVX with both soy IFs and exercise (OVX + IF + HIIT). The experimental rats underwent high-intensity interval training (5 days/week) and/or supplied a soy IF supplementation for six weeks. The cardiac microRNA-133 gene expression was analyzed using real-time PCR after six weeks of intervention. Results: Ovariectomy down-regulated cardiac microRNA133 gene expression, but 42 days of IF administration or HIIT reversed this effect (P &gt; 0.05). The HIIT reversed estrogen-deficiency-related microRNA-133 down-regulation greater than IF or combining IF and HIIT (P &gt; 0.05). The OVX + IF and OVX + IF + HIIT (P &gt; 0.05) showed no significant difference. Conclusions: Our results suggested that treatment with exercise, soy IF, and the combined treatment could benefit microRNA-133 in ovariectomized rats. This effect was significant when exercise alone was used to induce treatment. Thus, these treatments could offer protection in the menopausal period.

Prévention nutritionnelle de l’ostéoporose chez l’adulte

A Mediterranean diet appears to be beneficial for bone health. It is recommended for the prevention of osteoporosis, especially since this diet has other health benefits unlike an unbalanced Western diet. Exclusion diets among vegetarians and especially vegans are to be avoided in the prevention of osteoporosis. In vegetarians and especially vegans, vitamin D, calcium supplementation, and sufficient protein intake must be systematically prescribed in order to reduce the excess risk of fracture. The literature globally shows a positive effect of dairy products in terms of impact on bone mineral density and fracture risk. This effect appears more marked for fermented milk products (yogurt, cheese). It is recommended to consume several varied dairy products (2 to 3) daily to prevent osteoporosis. Regarding vitamin D fortified foods, the scientific evidence is not sufficient to affirm an equivalence with vitamin D supplementation in terms of bone health. Certain strains of probiotics can reduce bone loss in a modest way, but the target population, the optimal bacterial strains and the methods of consumption remain insufficiently defined to specifically recommend their use in the prevention of osteoporosis. For Western women, there is insufficient data to recommend a soy food consumption or isoflavone supplements for the prevention of osteoporosis.

Influences of Dietary Vitamin E, Selenium-Enriched Yeast, and Soy Isoflavone Supplementation on Growth Performance, Antioxidant Capacity, Carcass Traits, Meat Quality and Gut Microbiota in Finishing Pigs.

This study investigated the effects of dietary compound antioxidants on growth performance, antioxidant capacity, carcass traits, meat quality, and gut microbiota in finishing pigs. A total of 36 barrows were randomly assigned to 2 treatments with 6 replicates. The pigs were fed with a basal diet (control) or the basal diet supplemented with 200 mg/kg vitamin E, 0.3 mg/kg selenium-enriched yeast, and 20 mg/kg soy isoflavone. Dietary compound antioxidants decreased the average daily feed intake (ADFI) and feed to gain ratio (F/G) at d 14–28 in finishing pigs (p < 0.05). The plasma total protein, urea nitrogen, triglyceride, and malondialdehyde (MDA) concentrations were decreased while the plasma glutathione (GSH) to glutathione oxidized (GSSG) ratio (GSH/GSSG) was increased by compound antioxidants (p < 0.05). Dietary compound antioxidants increased loin area and b* value at 45 min, decreased backfat thickness at last rib, and drip loss at 48 h (p < 0.05). The relative abundance of colonic Peptococcus at the genus level was increased and ileal Turicibacter_sp_H121 abundance at the species level was decreased by dietary compound antioxidants. Spearman analysis showed a significant negative correlation between the relative abundance of colonic Peptococcus and plasma MDA concentration and meat drip loss at 48 h. Collectively, dietary supplementation with compound antioxidants of vitamin E, selenium-enrich yeast, and soy isoflavone could improve feed efficiency and antioxidant capacity, and modify the backfat thickness and meat quality through modulation of the gut microbiota community.

Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial

BackgroundLiterature suggests a relationship between estrogen levels and migraine headache pathogenesis. However, the effect of soy isoflavones on migraine characteristic remains unclear. This study aimed to investigate the effect of soy isoflavones on migraine characteristics and calcitonin gene-related peptide (CGRP) levels in women with migraine.MethodsEighty-three participants completed a randomized double-blind controlled trial, receiving 50 mg per day soy isoflavones or placebo supplementation for 8 weeks. Migraine severity, migraine days per month, frequency and duration of attacks, mental status, quality of life and serum CGRP levels were measured at baseline and the end of the intervention. Bivariate comparison and intention-to-treat (ITT) were used for analysis.ResultsSoy isoflavones intake resulted in a significant decrease in mean frequency (-2.36 vs -0.43, P < 0.001), duration (-2.50 vs -0.02, P < 0.001) of migraine attacks and CGRP level (-12.18 ng/l vs -8.62, P = 0.002) in compared to placebo group. Also, a significant improvement was found in quality of life (16.76 vs 2.52, P < 0.001). Although, reduction in the migraine severity and mental status did not reach a statistically significant level (P > 0.05).Conclusionsoy isoflavones supplementation may be considered as a complementary treatment for women with migraine to improve migraine characteristics and reduce the burden of disease.

Maternal immune activation and dietary soy isoflavone supplementation influence pig immune function but not muscle fiber formation.

The goals of this study were to determine the impact of maternal PRRSV infection on offspring muscle and immune development and the potential of dietary soy isoflavones to mitigate those effects. Thirteen first-parity gilts ("gilts") were randomly allotted into one of three treatments: not infected and fed a diet devoid of isoflavones (CON), infected with porcine reproductive and respiratory syndrome virus (PRRSV) and fed the control diet (POS) or that supplemented with 1,500 mg/kg soy-derived isoflavones (ISF). Gilts were inoculated with PRRSV intranasally on gestational day (GD) 70. After farrowing (GD 114 ± 2), 1-2 offspring ("pigs") closest to the average litter weight were selected either at birth (3 ± 2 d of age) or weaning (21 ± 2 d of age) to determine body, muscle, and organ weights as well as muscle cell number and size. Four weaned pigs of average body weight within each litter were selected for postnatal immune challenge. At PND 52, pigs were injected with 5 µg/kg BW lipopolysaccharide (LPS) intraperitoneally. Serum was collected at 0, 4, and 8 h following LPS administration to analyze tumor necrosis factor alpha (TNF-α). At PND 59, pigs were administered a novel vaccine to elicit an adaptive immune response. At PND 59, 66, and 73, peripheral blood mononuclear cells were isolated and T-cell populations determined by flow cytometry. Both POS and ISF pigs exhibited persistent PRRSV infections throughout the study (PND 1-73). At PND 3, whole body, muscle, and organ weights were not different (P > 0.22) between groups, with the exception of relative liver weight, which was increased (P < 0.05) in POS compared with CON pigs. At PND 21, ISF pigs had reduced (P ≤ 0.05) whole body and muscle weights, but greater (P < 0.05) kidney weight compared with CON, and greater (P < 0.05) relative liver weight compared with CON and POS. Muscle fiber number and size were not different (P > 0.39) between groups at birth or weaning. After LPS administration, TNF-α was greatest in ISF pigs (P < 0.05) at both 0 and 8 h post-challenge. At the peak time-point of 4 h post-challenge, ISF pigs had the greatest concentration of TNF-α and CON pigs had the lowest, with POS pigs being intermediate (P = 0.01). After vaccination, ISF offspring had shifts in T-cell populations indicating an impaired immune response. These data indicate that maternal PRRSV infection may impact offspring organ growth and immune function, particularly when the dam is supplemented with isoflavones.

Effect of Soy Isoflavones Compared to Estradiol Valerate in Menopausal Women assessed by Menopause Quality of Life Questionnaire

BACKGROUND: There has recently been a global effort to develop preparations that aim for benefits of hormone replacement therapy with minimal discomfort or risk while isoflavones administration found to relieve complaints related to menopause and has been widely carried out. AIM: The aim of the study is to determine the effect of soy isoflavone compared to estradiol valerate administration in postmenopausal women assessed by the Menopause Quality of Life (MENQOL) questionnaire. METHODS: This is an experimental study with pre-post test non-randomized design using data from postmenopausal women who were divided into two groups, namely, group I Estradiol Valerate group which is 16 menopausal women were given Estradiol Valerate and group II Soy Isoflavone Supplements group which is 16 menopausal women were given Soy Isoflavone Supplements. RESULTS: It was found that in estradiol valerate group, total MENQOL value before estradiol valerate administration was 81.56 ± 19.77, and after administration was 74.55 ± 16.82 with p = 0.002, which indicates there is a significant total MENQOL score difference before and after administration estradiol valerate. In the soy isoflavone group, the total MENQOL scores before soy isoflavone administration were 91.0 ± 16.31, and after administration was 83.08 ± 13.85 with p = 0.001, which indicated that there was a significant total MENQOL score difference between before and after administration soy isoflavone. CONCLUSION: In comparison of menopausal complaints based on MENQOL scale in Estradiol Valerate and Soy Isoflavone groups after intervention, it was shown that there were significant differences in total MENQOL value after intervention.

Soy isoflavones alleviate periodontal destruction in ovariectomized rats.

The purpose of this study was to investigate whether soy isoflavone supplementation is effective in preventing periodontal destruction exacerbated by estrogen deficiency (ED) and its potential mechanism. The progression of periodontitis is affected by host factors, such as smoking, diabetes mellitus, and steroid use. Bone loss in periodontitis can be aggravated by ED. A rat model of experimental periodontitis (EP) with ED was established by silk ligature and inoculation with Porphyromonas gingivalis, and some EP rats were subjected to bilateral ovariectomy (OVX). The treatment groups received an intravenous injection of 17-β-estradiol (E2 B) or soy isoflavones (SI) by gavage. The rats were euthanized, and the maxillary jaws, gingiva, and serum were harvested. Tight junction protein and interleukin (IL)-17 expression, reactive oxygen species (ROS) level, and periodontal destruction were assessed. In addition, we determined whether grainyhead-like 2 (GRHL2) is required for enhancing the epithelial barrier by SI in an in vitro P.gingivalis infection model. Estrogen deficiency impaired the expression of genes encoding tight junction proteins in the gingiva, increased IL-17 level, and accelerated alveolar bone resorption. SI treatment alleviated tight junction protein expression, decreased IL-17 and ROS levels, and prevented the absorption of alveolar bone. Furthermore, GRHL2 expression was significantly induced by SI in human oral keratinocytes-1 (HOK-1) cells; GRHL2 knockdown impaired the expression of OCLN and ZO-1 induced by SI treatment. Soy isoflavones alleviates periodontitis in OVX rats, as observed by the increased expression of tight junction proteins, and reduced IL-17 level and alveolar bone loss. The in vitro studies suggested that the enhancement of oral epithelial barrier by SI treatment was partially dependent on GRHL2.

The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women.

Introduction:Approximately one-third of a woman's life is spent in the menopausal phase. The unpleasant menopausal symptoms are unacceptable as a part of routine life. Indications of menopausal hormone therapy (MHT) are for alleviation of vasomotor symptoms, prevention of osteoporosis, and genitourinary symptoms associated with menopause. MHT is associated with an increased risk of breast cancer, cerebrovascular accidents, and coronary heart disease. Soy isoflavones have been extensively used as an alternative treatment in patients who cannot take MHT. The evidence of the efficacy of isoflavones in the literature is equivocal.Aim:The aim of the study was to evaluate the efficacy of soy isoflavone supplementation on menopausal symptoms in perimenopausal and postmenopausal women and to evaluate the effect on blood pressure (BP) and body mass index (BMI).Materials and Methods:A questionnaire-based prospective observational study was undertaken involving 39 perimenopausal and 61 postmenopausal women, who were prescribed 40 mg soy isoflavone supplements twice daily for 12 weeks. Menopause Rating Scale questionnaire was given to the patients before starting soy isoflavone therapy and at the end of the treatment; BP and BMI were also noted.Results:The total score of both the groups was comparable at baseline. Among perimenopausal and postmenopausal women, the highest score was noted in symptoms of somatic domain. At the completion of our study, the total scores improved significantly by 38.6% and 33.3% in perimenopausal and postmenopausal women, respectively. The greatest improvement was seen in somatic subscale (42.5%) and psychological subscale (42.5%) and the least in urogenital subscale (16.1%) for perimenopausal women. For postmenopausal women, the greatest improvement was seen in psychological subscale (40.0%) and the least in urogenital subscale (14.2%).Conclusion:Soy isoflavone supplementation is beneficial in both perimenopausal and postmenopausal women, more so in perimenopausal women. There is no beneficial effect of soy isoflavone supplementation on lowering systolic BP and BMI.

Effect of Soy Isoflavones Supplementation on Adiponectin Levels in Postmenopausal Women

Decreased adiponectin levels has been demonstrated in postmenopausal (PMP) women. Soy isoflavones, as an herbal product have been shown to increase adiponectin level but the results are inconclusive and inconsistent. The present study reassessed the data on the impact of soy isoflavones supplementation on adiponectin levels in PMP women through a meta-analysis. A systematic search was performed in the databases of PubMed, Web of science, Scopus and the Cochrane library. The literature search identified 830 studies with duplicates. Out of those, 80 were screened for title and abstract and 12 articles were ultimately selected for the analysis. Meta-regression and subgroup analyses, based on the moderator variables such as treatment duration, dose of soy isoflavones and BMI were performed. The quality of the studies was evaluated using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. The results revealed that soy isoflavones supplementation significantly increased the circulating level of adiponectin in PMP women (SMD: 0.36 µg/mL; 95% CI (0.05 to 0.66); P= 0.02). No publication bias was observed using Begg's (P = 0.38) and Egger's (P = 0.07) tests. Sensitivity analysis indicated the results were completely powerful and stable. Moreover, Meta-regression and subgroup analyses indicated a significant increase of adiponectin levels in subgroups of dose &gt; 50 mg and treatment duration less or equal 3 months. Our findings showed significantly increase in adiponectin levels after isoflavones-supplemented soy consumption in postmenopausal women, who received dose &gt; 50 mg of soy isoflavones in treatment duration ≤ 3 months.

Soy isoflavones supplementation improves reproductive performance and serum antioxidant status of sows and the growth performance of their offspring.

A total of 60sows (Landrace×Yorkshire, average parity was 1.39) were used to evaluate the effects of soy isoflavones (ISO) supplementation on reproductive performance, serum antioxidant enzyme parameters, and milk compositions of sows, and the growth performance of offspring. Sows were randomly assigned to 4groups based on the parity. There were 15 replicates per treatment. Dietary treatments were based on a corn-soybean meal-based basal diet and supplemented with 0, 10, 20, or 40mg/kg ISO. With the increase of the ISO dosage, average daily feed intake of sows increased linearly; oestrus interval decreased linearly and quadratically. In addition, on day 10 of lactation, linear increases in serum superoxide dismutase levels, linear and quadratic increases in serum total antioxidant capacity, and linear decreases in serum malondialdehyde levels were observed in increasing ISO dosage in the diet of sows. The body weight on day 10 and 21 and the average daily gain during days 3-10 and 3-21 of offspring increased linearly at graduated doses of ISO increased. Therefore, feeding sows with graded levels of ISO containing diet during late-gestation and lactation periods improved the reproductive performance of sows and the growth performance of their offspring in a dose-dependent manner.

Effects of soy isoflavones on intake, body weight, sex hormones, antioxidant performance, and semen quality in Xinong Saanen goats

ABSTRACT Efficacy of soy isoflavones to promote semen quality by improving antioxidant parameters in Xinong Saanen goats was explored. Soy isoflavones (SI), regulator of steroid hormone synthesis and antioxidant in organism, was supplemented in a total mixed ration of male Xinong Saanen dairy goats to study their effects on intake, body weight, level of testosterone and oestradiol, antioxidant performance, and semen quality. Supplementation with SI increased (P < 0.05) dry matter intake expressed as kg/day or % of body weight, with body weight remaining unchanged. In animals receiving SI supplementation, we observed increases (P < 0.05) in serum superoxide dismutase and total antioxidant capacity and decreases in oestradiol and malondialdehyde concentrations in comparison to the Control, while testosterone and glutathione peroxidase remained unchanged. An increase (p < 0.05) in plasma membrane integrity of sperm were observed in bucks received SI supplementation with no other effects on semen quality such as seminal pH, ejaculate volume, viability, motility, and acrosome integrity. The results indicated that SI supplementation improved semen characteristics via enhancing antioxidant parameters. Highlights Supplementation of soy isoflavones increased feed intake in Xinong Saanen bucks. Soy isoflavones decreased serum oestradiol but not testosterone concentrations. Soy isoflavones could be used as a safe, effective, and natural antioxidant in dairy goats. It alleviated oxidative stress, without negative influence on sperm quality of Xinong Saanen bucks.

Effects of soy isoflavone supplementation on patients with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials.

Diabetic nephropathy (DN) is a microvascular complication that is becoming a worldwide public health concern. The aim of this study was to assess the effects of dietary soy isoflavone intervention on renal function and metabolic syndrome markers in DN patients. Seven databases including Medline, the Cochrane Central Register of Controlled Trials, Science Direct, Web of Science, Embase, China National Knowledge Infrastructure, and WanFang were searched for controlled trials that assessed the effects of soy isoflavone treatment in DN patients. Finally, a total of 141 patients from 7 randomized controlled trials were included. The meta-analysis showed that dietary soy isoflavones significantly decreased 24-hour urine protein, C-reactive protein (CRP), blood urea nitrogen (BUN), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and fasting blood glucose (FBG) in DN patients. The standard mean difference was -2.58 (95% CI: -3.94, -1.22; P = 0.0002) for 24-hour urine protein, -0.67 (95% CI: -0.94, -0.41; P < 0.00001) for BUN, -6.16 (95% CI: -9.02, -3.31; P < 0.0001) for CRP, -0.58 (95% CI: -0.83, -0.33; P < 0.00001) for TC, -0.41 (95% CI: -0.66, -0.16; P < 0.00001) for TG, -0.68 (95% CI: -0.94, -0.42; P < 0.00001) for LDL-C, and -0.39 (95% CI: -0.68, -0.10; P = 0.008) for FBG. Therefore, soy isoflavones may ameliorate DN by significantly decreasing 24-hour urine protein, BUN, CRP, TC, TG, LDL-C, and FBG.

Soy Isoflavone Supplementation Reduces RANKL/OPG Ratio on Postmenopausal Women with Osteopenia

Soy Isoflavone Supplementation Reduces RANKL/OPG Ratio on Postmenopausal Women with Osteopenia